202 related articles for article (PubMed ID: 11041468)
1. Hemodialysis catheter-associated fibrin sheaths: treatment with a low-dose rt-PA infusion.
Savader SJ; Haikal LC; Ehrman KO; Porter DJ; Oteham AC
J Vasc Interv Radiol; 2000 Oct; 11(9):1131-6. PubMed ID: 11041468
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hemodialysis catheter-associated fibrin sheaths by rt-PA infusion: critical analysis of 124 procedures.
Savader SJ; Ehrman KO; Porter DJ; Haikal LC; Oteham AC
J Vasc Interv Radiol; 2001 Jun; 12(6):711-5. PubMed ID: 11389222
[TBL] [Abstract][Full Text] [Related]
3. Restoration of patency in failing tunneled hemodialysis catheters: a comparison of catheter exchange, exchange and balloon disruption of the fibrin sheath, and femoral stripping.
Janne d'Othée B; Tham JC; Sheiman RG
J Vasc Interv Radiol; 2006 Jun; 17(6):1011-5. PubMed ID: 16778235
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous fibrin sheath stripping versus transcatheter urokinase infusion for malfunctioning well-positioned tunneled central venous dialysis catheters: a prospective, randomized trial.
Gray RJ; Levitin A; Buck D; Brown LC; Sparling YH; Jablonski KA; Fessahaye A; Gupta AK
J Vasc Interv Radiol; 2000 Oct; 11(9):1121-9. PubMed ID: 11041467
[TBL] [Abstract][Full Text] [Related]
5. Restoration of flow following haemodialysis catheter thrombus. Analysis of rt-PA infusion in tunnelled dialysis catheters.
Davies J; Casey J; Li C; Crowe AV; McClelland P
J Clin Pharm Ther; 2004 Dec; 29(6):517-20. PubMed ID: 15584939
[TBL] [Abstract][Full Text] [Related]
6. Reteplase for dysfunctional hemodialysis catheter clearance.
Hilleman DE; Dunlay RW; Packard KA
Pharmacotherapy; 2003 Feb; 23(2):137-41. PubMed ID: 12587800
[TBL] [Abstract][Full Text] [Related]
7. Fibrin sheath stripping versus catheter exchange for the treatment of failed tunneled hemodialysis catheters: randomized clinical trial.
Merport M; Murphy TP; Egglin TK; Dubel GJ
J Vasc Interv Radiol; 2000 Oct; 11(9):1115-20. PubMed ID: 11041466
[TBL] [Abstract][Full Text] [Related]
8. Utility of percutaneous intervention in the management of tunneled hemodialysis catheters.
Angle JF; Shilling AT; Schenk WG; Bissonette EA; Stadtlander KS; Hagspiel KD; Spinosa DJ; Leung DA; Matsumoto AH
Cardiovasc Intervent Radiol; 2003; 26(1):9-18. PubMed ID: 12391516
[TBL] [Abstract][Full Text] [Related]
9. Comparison of intensive versus standard hemodialysis central venous catheter dysfunction protocol using rt-PA: a quality assurance initiative.
Wilson JA; Mossop P; Soroka SD; Dipchand C; Drost S; Sheehy N; Tennankore K
J Vasc Access; 2016; 17(2):143-50. PubMed ID: 26847735
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of percutaneous fibrin sheath stripping in restoring patency of tunneled hemodialysis catheters.
Brady PS; Spence LD; Levitin A; Mickolich CT; Dolmatch BL
AJR Am J Roentgenol; 1999 Oct; 173(4):1023-7. PubMed ID: 10511171
[TBL] [Abstract][Full Text] [Related]
11. Analysis of rt-PA infusion in tunnelled dialysis catheters.
Davies J; Casey J; Li C; Crowe AV; McClelland P
EDTNA ERCA J; 2005; 31(2):75-8. PubMed ID: 16180551
[TBL] [Abstract][Full Text] [Related]
12. Tissue plasminogen activator (t-PA) efficacy in the restoration of hemodialysis catheter function.
Meers C; Toffelmire EB
CANNT J; 1999; 9(4):25-8. PubMed ID: 15714785
[TBL] [Abstract][Full Text] [Related]
13. Venous port salvage utilizing low dose tPA.
Whigham CJ; Lindsey JI; Goodman CJ; Fisher RG
Cardiovasc Intervent Radiol; 2002; 25(6):513-6. PubMed ID: 12391517
[TBL] [Abstract][Full Text] [Related]
14. Fibrin sheaths in central venous port catheters: treatment with low-dose, single injection of urokinase on an outpatient basis.
Chang DH; Mammadov K; Hickethier T; Borggrefe J; Hellmich M; Maintz D; Kabbasch C
Ther Clin Risk Manag; 2017; 13():111-115. PubMed ID: 28182117
[TBL] [Abstract][Full Text] [Related]
15. Exchange of poorly functioning tunneled permanent hemodialysis catheters.
Garofalo RS; Zaleski GX; Lorenz JM; Funaki B; Rosenblum JD; Leef JA
AJR Am J Roentgenol; 1999 Jul; 173(1):155-8. PubMed ID: 10397118
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of tissue plasminogen activator administration on patency of hemodialysis access catheters.
Daeihagh P; Jordan J; Chen J; Rocco M
Am J Kidney Dis; 2000 Jul; 36(1):75-9. PubMed ID: 10873875
[TBL] [Abstract][Full Text] [Related]
17. Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator.
Hemmelgarn BR; Moist LM; Lok CE; Tonelli M; Manns BJ; Holden RM; LeBlanc M; Faris P; Barre P; Zhang J; Scott-Douglas N;
N Engl J Med; 2011 Jan; 364(4):303-12. PubMed ID: 21268722
[TBL] [Abstract][Full Text] [Related]
18. Tip Design of Hemodialysis Catheters Influences Thrombotic Events and Replacement Rate.
Petridis C; Nitschke M; Lehne W; Smith E; Goltz JP; Lehnert H; Meier M
Eur J Vasc Endovasc Surg; 2017 Feb; 53(2):262-267. PubMed ID: 27876561
[TBL] [Abstract][Full Text] [Related]
19. Conversion of temporary hemodialysis catheters to tunneled hemodialysis catheters.
Falk A; Parthasarathy S
Clin Nephrol; 2005 Mar; 63(3):209-14. PubMed ID: 15786822
[TBL] [Abstract][Full Text] [Related]
20. The natural history of tunneled hemodialysis catheters removed or exchanged: a single-institution experience.
Alomari AI; Falk A
J Vasc Interv Radiol; 2007 Feb; 18(2):227-35. PubMed ID: 17327555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
